Macromolecular Bioscience,
Journal Year:
2024,
Volume and Issue:
24(6)
Published: Jan. 24, 2024
Hydrogels
are
3D
networks
swollen
with
water.
They
biocompatible,
strong,
and
moldable
emerging
as
a
promising
biomedical
material
for
regenerative
medicine
tissue
engineering
to
deliver
therapeutic
genes.
The
excellent
natural
extracellular
matrix
simulation
properties
of
hydrogels
enable
them
be
co-cultured
cells
or
enhance
the
expression
viral
non-viral
vectors.
Its
biocompatibility,
high
strength,
degradation
performance
also
make
action
process
carriers
in
tissues
more
ideal,
making
it
an
ideal
material.
It
has
been
shown
that
hydrogel-based
gene
delivery
technologies
have
potential
play
therapy-relevant
roles
organs
such
bone,
cartilage,
nerve,
skin,
reproductive
organs,
liver
animal
experiments
preclinical
trials.
This
paper
reviews
recent
articles
on
explains
manufacture,
applications,
developmental
timeline,
limitations,
future
directions
techniques.
Journal of Xenobiotics,
Journal Year:
2024,
Volume and Issue:
14(3), P. 827 - 872
Published: June 24, 2024
In
the
recent
past,
formulation
and
development
of
nanocarriers
has
been
elaborated
into
broader
fields
opened
various
avenues
in
their
preclinical
clinical
applications.
particular,
cellular
membrane-based
nanoformulations
have
formulated
to
surpass
surmount
limitations
restrictions
associated
with
naïve
or
free
forms
therapeutic
compounds
circumvent
physicochemical
immunological
barriers
including
but
not
limited
systemic
barriers,
microenvironmental
roadblocks,
other
subcellular
hinderances-which
are
quite
heterogeneous
throughout
diseases
patient
cohorts.
These
drug
delivery
overcome
through
mesenchymal
cells
precision
therapeutics,
where
these
interventions
led
significant
enhancements
efficacies.
However,
still
focuses
on
optimization
paradigms
a
one-size-fits-all
resolutions.
As
stem
cell
engineered
highly
diversified
fashions,
being
optimized
for
delivering
payloads
more
better
personalized
modes,
entering
arena
as
well
nanomedicine.
this
Review,
we
included
some
advanced
which
designed
utilized
both
non-personalized
applicability
can
be
employed
improvements
nanotherapeutics.
present
report,
authors
focused
aspects
advancements
nanoparticle
conceptions
several
roadblocks
It
suggested
that
well-informed
designing
will
lead
appreciable
efficacy
payload
approaches
also
enable
tailored
customized
designs
MSC-based
applications,
finally
amending
outcomes.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: July 15, 2024
The
T-helper
17
(Th17)
cell
and
regulatory
T
(Treg)
axis
plays
a
crucial
role
in
the
development
of
multiple
sclerosis
(MS),
which
is
regarded
as
an
immune
imbalance
between
pro-inflammatory
cytokines
maintenance
tolerance.
Mesenchymal
stem
(MSC)-mediated
therapies
have
received
increasing
attention
MS
research.
In
its
animal
model
experimental
autoimmune
encephalomyelitis,
MSC
injection
was
shown
to
alter
differentiation
CD4
Frontiers in Neurology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 24, 2025
Background
The
study
aims
were
to
systematically
review
and
analyze
preclinical
research
on
the
efficacy
of
exosomes
derived
from
various
mesenchymal
stem
cell
sources
(MSC-exos)
for
treatment
spinal
cord
contusion
injury
(SCI)
in
small
animal
models.
Methods
We
conducted
a
systematic
search
PubMed,
Embase
Google
Scholar
databases
their
inception
through
February
29,
2024,
identify
eligible
English-language
studies
based
predefined
inclusion
exclusion
criteria.
Two
independent
investigators
performed
literature
screening,
data
extraction
bias
assessment.
Results
A
total
235
rats
used
assess
locomotor
recovery
at
initial
assessment,
exhibited
significant
improvement
hind
limb
movement
those
treated
with
exosomes,
as
indicated
by
statistically
increase
Basso-Beattie-Bresnahan
(BBB)
scores
(MD:
1.26,
95%
CI:
1.14–1.38,
p
<
0.01)
compared
controls.
This
trend
persisted
final
assessment
across
21
studies,
pooled
analysis
confirming
similar
results
1.56,
1.43–1.68,
0.01).
Funnel
plot
asymmetry
BBB
both
baseline
endpoint
assessments,
suggesting
potential
publication
bias.
Exosomes
bone
marrow,
adipose
tissue,
umbilical
or
human
placental
MSCs.
Meta-analysis
showed
no
differences
therapeutic
among
these
MSC-exos
time
points.
Conclusion
demonstrated
considerable
promise
improving
motor
function
SCI-affected
rats,
marrow
MSC-derived
having
particularly
notable
effectiveness.
Materials Today Bio,
Journal Year:
2024,
Volume and Issue:
25, P. 100967 - 100967
Published: Jan. 21, 2024
Limb
ischemia
is
a
refractory
disease
characterized
by
persistent
inflammation,
insufficient
angiogenesis,
and
tissue
necrosis.
Although
mesenchymal
stem
cells
(MSCs)
have
shown
potential
for
treating
limb
ischemia,
their
therapeutic
effects
are
limited
low
engraftment
rates.
Therefore,
developing
an
optimal
MSC
delivery
system
that
enhances
cell
viability
imperative.
Selenium,
known
its
cytoprotective
properties
in
various
types,
offers
strategy
to
enhance
effect
of
MSCs.
In
this
study,
we
evaluated
the
selenium
on
MSCs,
developed
injectable
thermosensitive
selenium-containing
hydrogel
based
PLGA-PEG-PLGA
triblock
copolymer,
as
carrier
improve
after
engraftment.
The
biocompatibility,
biodegradability,
capabilities
hydrogels
were
assessed.
Furthermore,
MSCs
encapsulated
within
was
using
cellular
animal
experiments.
Selenium
protects
from
oxidative
damage
upregulating
GPX4
through
transcriptional
mechanism.
exhibited
favorable
antioxidant
properties.
It
can
be
easily
injected
into
target
area
liquid
form
at
room
temperature
undergoes
gelation
body
temperature,
thereby
preventing
diffusion
promoting
cytoprotection
effectively
inhibited
macrophage
M1
polarization
while
M2
polarization,
thus
accelerating
angiogenesis
restoring
blood
perfusion
ischemic
limbs.
This
study
demonstrated
promising
method
delivery.
By
addressing
challenge
retention
rate,
which
major
obstacle
application,
improves
ischemia.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: April 12, 2024
Abstract
The
current
first-line
treatment
for
repairing
cartilage
defects
in
clinical
practice
is
the
creation
of
microfractures
(MF)
to
stimulate
release
mesenchymal
stem
cells
(MSCs);
however,
this
method
has
many
limitations.
Recent
studies
have
found
that
MSC-derived
extracellular
vesicles
(MSC-EVs)
play
an
important
role
tissue
regeneration.
This
study
aimed
verify
whether
MSC-EVs
promote
damage
repair
mediated
by
MFs
and
explore
mechanisms.
In
vitro
experiments
showed
human
umbilical
cord
Wharton’s
jelly
(hWJMSC-EVs)
promoted
vitality
chondrocytes
proliferation
differentiation
ability
bone
marrow-derived
MSCs.
was
mainly
because
hWJMSC-EVs
carry
integrin
beta-1
(ITGB1),
MSCs
overexpress
ITGB1
after
absorbing
EVs,
thereby
activating
transforming
growth
factor-β/Smad2/3
axis.
a
rabbit
knee
joint
model
osteochondral
defect
repair,
injection
different
concentrations
into
cavity
concentration
50
µg/ml
significantly
improved
formation
transparent
MF
surgery.
Extraction
regenerated
revealed
changes
ITGB1,
factor-β,
Smad2/3
were
directly
proportional
cartilage.
summary,
Graphical
abstract
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 331 - 331
Published: Jan. 31, 2025
Objective:
This
study
aims
to
explore
the
role
of
angiogenesis-related
genes
in
chronic
lung
diseases
(ILD
and
COPD)
using
bioinformatics
methods,
with
goal
identifying
novel
therapeutic
targets
slow
disease
progression
prevent
its
deterioration
into
fibrosis
or
pulmonary
artery
hypertension.
Methods:
The
research
methods
encompassed
differential
analysis,
WGCNA
(Weighted
Gene
Co-expression
Network
Analysis),
multiple
machine
learning
approaches
screen
for
key
genes.
Set
Enrichment
Analysis
(GSEA),
Ontology
(GO),
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
were
utilized
assess
related
biological
functions
pathways.
Additionally,
immune
cell
infiltration
was
analyzed
evaluate
status
correlation
between
immunity.
Results:
COPD
ILD
are
closely
associated
pathways
angiogenesis,
responses,
others,
both
groups
linked
inflammation-related
signaling
established
a
disease-related
gene
set
comprising
171
further
screened
out
21
angiogenesis.
Ultimately,
four
genes—COL10A1,
EDN1,
MMP1,
RRAS—were
identified
through
methods.
These
angiogenesis
processes,
clustering
analysis
based
on
them
can
reflect
different
states
variations
infiltration.
Conclusions:
COL10A1,
RRAS
represent
potential
slowing
preventing
their
deterioration.
Furthermore,
monocytes
exhibited
consistent
patterns
across
control
groups,
as
well
among
subgroups,
suggesting
significant
development
diseases.
Journal of Orthopaedic Surgery and Research,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: March 25, 2025
Nonunion
of
fractures
is
a
major
unsolved
problem
in
clinical
treatment
and
prognosis
orthopedics.
Bone
marrow
mesenchymal
stem
cell
(BMSC)
exosomes
have
been
proven
to
be
involved
mediating
tissue
bone
regeneration
variety
diseases.
However,
the
role
BMSC
fracture
nonunion
unclear.
were
injected
into
rat
model
fracture,
fracture-healing
site
was
detected
by
micro-CT
serum
metabolites
analyzed
LC-MS/MS.
The
results
showed
that
could
successfully
isolated
from
BMSCs
cultured
an
exosome-free
medium.
Compared
with
group,
exosome-treated
rats
healing
obviously.
PBS
there
158
up-regulated
differential
abundance
(DAMs)
79
down-regulated
DAMs
BMSC-exo
group.
enriched
'Th1
Th2
differentiation',
'ErbB
signaling
pathway',
'PPAR
pathway'
'HIF-1
related
function
proliferation
differentiation.
DAMs-PE
HIF-1
pathway
metabolite
promote
healing.
Our
study
reveals
mechanism
which
BMSC-exosome
improves
process
through
metabolic
reprogramming
provides
reference
for
nonunion.